ReviewJournal of hematology & oncology2021

Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting.

Jing-Zhou Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.